Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

Contrast-Enhanced Computed Tomography Screening Is Effective for Identifying Asymptomatic Venous Thromboembolism Not Prevented by Prophylaxis After Total Knee Arthroplasty

International Society for Technology in Arthroplasty (ISTA)



Abstract

Introduction:

One of the complications occurring after total knee arthroplasty (TKA) is venous thromboembolism (VTE). The current screening techniques for VTE are venography, lower extremity vascular ultrasound, pulmonary scintigraphy, and contrast-enhanced computed tomography (CT). Although venography and lower extremity vascular ultrasound can detect deep venous thrombosis (DVT) in the lower extremities, pulmonary thrombosis poses a diagnostic problem. We performed contrast-enhanced CT screening for DVT and pulmonary embolism (PE) after TKA, and assessed the efficacy of the following prophylactics for VTE: fondaparinux, enoxaparin, and edoxaban.

Materials and Methods:

Subjects included 219 patients (260 knees) undergoing TKA at our hospital between April 2007 and November 2012. The 260 subject knees were divided as follows: group C, 31 cases in which DVT prophylactics were not used (April 2007 to October 2008); group F, 107 cases receiving fondaparinux 2.5 mg/day (July 2007 to October 2009); group ENO, 87 cases receiving enoxaparin 2000–4000 IU/day (November 2009 to October 2011); and group EDO, 35 cases receiving edoxaban 15–30 mg/day (November 2011 to November 2012). Contrast-enhanced CT images were obtained from the pulmonary apex to the foot for diagnosis of VTE. Groups were compared for incidence of symptomatic PE, asymptomatic PE, DVT-negative asymptomatic PE, DVT-positive asymptomatic PE, and DVT.

Results:

Incidence of symptomatic PE tended to be lower in group ENO than in group C (p = 0.067), but no statistically significant differences in asymptomatic PE were observed between any groups (Figure 1). DVT-negative asymptomatic PE (Figure 2) was present in 2 cases in group C (6.5%), 14 cases in group F (13.1%), 3 cases in group ENO (3.4%), and 2 cases in group EDO (5.7%) (Figure 1). Patients diagnosed with symptomatic PE presented only with mild clinical symptoms and physical findings. As a result, PE was not suspected from clinical findings alone. The diagnosis of symptomatic PE was confirmed by the presence of thrombosis in the pulmonary artery on contrast-enhanced CT (Figure 3).

Conclusion:

Asymptomatic PE is not prevented by prophylaxis after TKA. Contrast-enhanced CT screening is effective for identifying asymptomatic VTE, especially asymptomatic PE.


*Email: